Dow set to break 12-day winning run; Trump speech looms

Image
Reuters
Last Updated : Feb 28 2017 | 11:48 PM IST

By Yashaswini Swamynathan

REUTERS - U.S. stocks traded lower on Tuesday, setting up the Dow to snap a 12-day winning streak, as financial and consumer discretionary stocks weighed and investors awaited President Donald Trump's speech to a joint session of Congress.

Trump's promises of tax reform, infrastructure spending and simpler regulations have sparked a post-election rally that has propelled the main U.S. market indexes to record highs.

"What we're looking for tonight is just more meat on those bones," said Mark Spellman, portfolio manager at Alpine Funds in Purchase, New York.

"We've gotten these generalities and we're trying to figure out how things are going to be constructed," he said.

The address at 9:00 p.m. ET (0200 GMT) could touch on tax reforms, defense spending and his plans to overhaul the U.S. healthcare system.

But on Wall Street, financial and consumer discretionary stocks dropped and pulled down the three major indexes, which were set for their worst one-day decline in four weeks.

Target slumped 12.2 percent and was on track for its worst day since December 2008, after the retailer's full-year profit forecast missed estimates and the company said it would take a $1 billion hit to its operating profit.

Also weighing on sentiment was data that showed U.S. economic growth slowed in the fourth quarter.

The dollar dropped 0.27 percent to 100.85 against a basket of major currencies, while safe-haven gold edged up 0.34 percent.

At 12:23 p.m. ET the Dow Jones Industrial Average was down 35.54 points, or 0.17 percent, at 20,801.9, the S&P 500 was down 7.9 points, or 0.33 percent, at 2,361.85 and the Nasdaq Composite was down 36.94 points, or 0.63 percent, at 5,824.96.

Seven of the 11 major S&P sectors were lower, led by financials and discretionary.

Traditionally defensive plays, utilities and consumer staples, were higher.

Charles Schwab was the top drag on the financial sector after the company said it would cut its ETF trade and online equity fees, following similar cuts by Fidelity Investments. TD Ameritrade dropped 10.5 percent and was the biggest loser on the Nasdaq.

Priceline rose 5.9 percent to $1,728.87, offsetting Target's impact on the S&P, following quarterly revenue that blew past estimates.

Declining issues outnumbered advancers on the NYSE by 1,878 to 961. On the Nasdaq, 2,121 issues fell and 674 advanced.

The S&P 500 index showed 46 new 52-week highs and four new lows, while the Nasdaq recorded 97 new highs and 38 new lows.

(Reporting by Yashaswini Swamynathan in Bengaluru; Editing by Sriraj Kalluvila)

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 28 2017 | 11:30 PM IST

Next Story